Neogen Corp 2013 AR2
The report outlines Neogen Corporation's financial and operational achievements for the fiscal year ended May 31, 2013, highlighting a record revenue of $207.5 million. It emphasizes the company's mission to lead in food and animal safety solutions, addressing global food security challenges through scientific innovation. Key developments include the expansion of biosecurity products, advanced foodborne pathogen detection systems like ANSR, and agricultural genomics. Additionally, the report details strategic acquisitions, including Macleod Pharmaceuticals and Scidera Genomics, which strengthen Neogen's market position and global distribution channels.
Company: Neogen Corp
Sector: Manufacturing
Country: United States
Year: 2013
Type: AR2
Pages: 36
Back to company
Neogen Corp
Annual Report
The report outlines Neogen Corporation's financial and operational achievements for the fiscal year ended May 31, 2013, highlighting a record revenue of $207.5 million. It emphasizes the company's mission to lead in food and animal safety solutions, addressing global food security challenges through scientific innovation. Key developments include the expansion of biosecurity products, advanced foodborne pathogen detection systems like ANSR, and agricultural genomics. Additionally, the report details strategic acquisitions, including Macleod Pharmaceuticals and Scidera Genomics, which strengthen Neogen's market position and global distribution channels.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jun 1, 2012 - May 31, 2013
Fiscal Year
2013
Published
Aug 1, 2013
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees